Abiopharma

🔍 Williams Anre D (Director)

Company: Navan, Inc. (NAVN)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 412 shares of Class A Common Stock at $28.56 per share (Direct)
  Date: 2026-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 226,029.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents Class A Common Stock underlying restricted stock units that are fully vested on the grant date issued to the Reporting Person in lieu of a cash retainer for board service in the amount of $11,750.
• F2: Includes 24,983 RSUs, each of which represents a contingent right to receive one share of Issuer's Class A Common Stock upon vesting.